Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects - PubMed (original) (raw)

• Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
  Wiley MM, Khatri B, Joachims ML, Tessneer KL, Stolarczyk AM, Rasmussen A, Anaya JM, Aqrawi LA, Bae SC, Baecklund E, Björk A, Brun JG, Bucher SM, Dand N, Eloranta ML, Engelke F, Forsblad-d'Elia H, Fugmann C, Glenn SB, Gong C, Gottenberg JE, Hammenfors D, Imgenberg-Kreuz J, Jensen JL, Johnsen SJA, Jonsson MV, Kelly JA, Khanam S, Kim K, Kvarnström M, Mandl T, Martín J, Morris DL, Nocturne G, Norheim KB, Olsson P, Palm Ø, Pers JO, Rhodus NL, Sjöwall C, Skarstein K, Taylor KE, Tombleson P, Thorlacius GE, Venuturupalli S, Vital EM, Wallace DJ, Grundahl KM, Radfar L, Brennan MT, James JA, Scofield RH, Gaffney PM, Criswell LA, Jonsson R, Appel S, Eriksson P, Bowman SJ, Omdal R, Rönnblom L, Warner BM, Rischmueller M, Witte T, Farris AD, Mariette X, Shiboski CH; Sjögren’s International Collaborative Clinical Alliance (SICCA); Wahren-Herlenius M, Alarcón-Riquelme ME; PRECISESADS Clinical Consortium; Ng WF; UK Primary Sjögren’s Syndrome Registry; Sivils KL, Guthridge JM, Adrianto I, Vyse TJ, Tsao BP, Nordmark G, Lessard CJ. Wiley MM, et al. bioRxiv [Preprint]. 2023 Oct 6:2023.10.05.561076. doi: 10.1101/2023.10.05.561076. bioRxiv. 2023. PMID: 39071447 Free PMC article. Preprint.
• CXCL9 may serve as a potential biomarker for primary Sjögren's syndrome with extra-glandular manifestations.
  Hong J, Cheng H, Wang P, Wu Y, Lu S, Zhou Y, Wang XB, Zhu X. Hong J, et al. Arthritis Res Ther. 2024 Jan 17;26(1):26. doi: 10.1186/s13075-023-03229-x. Arthritis Res Ther. 2024. PMID: 38229121 Free PMC article.
• Application of omics in Sjögren's syndrome.
  He W, Lu Y, Shi R, An Q, Zhao J, Gao X, Zhang L, Ma D. He W, et al. Inflamm Res. 2023 Dec;72(12):2089-2109. doi: 10.1007/s00011-023-01797-x. Epub 2023 Oct 25. Inflamm Res. 2023. PMID: 37878024 Review.
• Current Views on Pathophysiology and Potential Therapeutic Targets in Sjögren's Syndrome: A Review from the Perspective of Viral Infections, Toll-like Receptors, and Long-Noncoding RNAs.
  Horai Y, Shimizu T, Umeda M, Nishihata SY, Nakamura H, Kawakami A. Horai Y, et al. J Clin Med. 2023 Sep 10;12(18):5873. doi: 10.3390/jcm12185873. J Clin Med. 2023. PMID: 37762814 Free PMC article. Review.
• Diagnostic markers and potential therapeutic agents for Sjögren's syndrome screened through multiple machine learning and molecular docking.
  Zhou L, Wang H, Zhang H, Wang F, Wang W, Cao Q, Wei Z, Zhou H, Xin S, Zhang J, Shi X. Zhou L, et al. Clin Exp Immunol. 2023 Jun 5;212(3):224-238. doi: 10.1093/cei/uxad037. Clin Exp Immunol. 2023. PMID: 36988140 Free PMC article.